Radiotherapy Equipment
Radiotherapy Equipment market is segmented by region (country), players, by Type and by Applicati ... Read More
1 Study Coverage 1.1 Transdermal Skin Patch Product Introduction 1.2 Global Transdermal Skin Patch Outlook 2017 VS 2022 VS 2028 1.2.1 Global Transdermal Skin Patch Sales in US$ Million for the Year 2017-2028 1.2.2 Global Transdermal Skin Patch Sales in Volume for the Year 2017-2028 1.3 United States Transdermal Skin Patch Outlook 2017 VS 2022 VS 2028 1.3.1 United States Transdermal Skin Patch Sales in US$ Million for the Year 2017-2028 1.3.2 United States Transdermal Skin Patch Sales in Volume for the Year 2017-2028 1.4 Transdermal Skin Patch Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Transdermal Skin Patch in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Transdermal Skin Patch Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Transdermal Skin Patch Market Dynamics 1.5.1 Transdermal Skin Patch Industry Trends 1.5.2 Transdermal Skin Patch Market Drivers 1.5.3 Transdermal Skin Patch Market Challenges 1.5.4 Transdermal Skin Patch Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Transdermal Skin Patch Market Segment by Type 2.1.1 Fentanyl Transdermal Skin Patch 2.1.2 Nicotine Transdermal Skin Patch 2.1.3 Clonidine Transdermal Skin Patch 2.1.4 Buprenorphine Transdermal Skin Patch 2.2 Global Transdermal Skin Patch Market Size by Type 2.2.1 Global Transdermal Skin Patch Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Transdermal Skin Patch Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Transdermal Skin Patch Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Transdermal Skin Patch Market Size by Type 2.3.1 United States Transdermal Skin Patch Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Transdermal Skin Patch Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Transdermal Skin Patch Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Transdermal Skin Patch Market Segment by Application 3.1.1 Relieve Severe Pain 3.1.2 Stop Smoking Cigarettes 3.1.3 Treat an Overactive Bladder 3.1.4 Others 3.2 Global Transdermal Skin Patch Market Size by Application 3.2.1 Global Transdermal Skin Patch Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Transdermal Skin Patch Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Transdermal Skin Patch Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Transdermal Skin Patch Market Size by Application 3.3.1 United States Transdermal Skin Patch Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Transdermal Skin Patch Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Transdermal Skin Patch Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Transdermal Skin Patch Competitor Landscape by Company 4.1 Global Transdermal Skin Patch Market Size by Company 4.1.1 Top Global Transdermal Skin Patch Manufacturers Ranked by Revenue (2021) 4.1.2 Global Transdermal Skin Patch Revenue by Manufacturer (2017-2022) 4.1.3 Global Transdermal Skin Patch Sales by Manufacturer (2017-2022) 4.1.4 Global Transdermal Skin Patch Price by Manufacturer (2017-2022) 4.2 Global Transdermal Skin Patch Concentration Ratio (CR) 4.2.1 Transdermal Skin Patch Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Transdermal Skin Patch in 2021 4.2.3 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Transdermal Skin Patch Manufacturing Base Distribution, Product Type 4.3.1 Global Transdermal Skin Patch Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Transdermal Skin Patch Product Type 4.3.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Transdermal Skin Patch Market Size by Company 4.5.1 Top Transdermal Skin Patch Players in United States, Ranked by Revenue (2021) 4.5.2 United States Transdermal Skin Patch Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Transdermal Skin Patch Sales by Players (2020, 2021 & 2022) 5 Global Transdermal Skin Patch Market Size by Region 5.1 Global Transdermal Skin Patch Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Transdermal Skin Patch Market Size in Volume by Region (2017-2028) 5.2.1 Global Transdermal Skin Patch Sales in Volume by Region: 2017-2022 5.2.2 Global Transdermal Skin Patch Sales in Volume Forecast by Region (2023-2028) 5.3 Global Transdermal Skin Patch Market Size in Value by Region (2017-2028) 5.3.1 Global Transdermal Skin Patch Sales in Value by Region: 2017-2022 5.3.2 Global Transdermal Skin Patch Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Transdermal Skin Patch Market Size YoY Growth 2017-2028 6.1.2 North America Transdermal Skin Patch Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Transdermal Skin Patch Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Transdermal Skin Patch Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Transdermal Skin Patch Market Size YoY Growth 2017-2028 6.3.2 Europe Transdermal Skin Patch Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Transdermal Skin Patch Market Size YoY Growth 2017-2028 6.4.2 Latin America Transdermal Skin Patch Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Transdermal Skin Patch Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Hisamitsu Pharmaceutical 7.1.1 Hisamitsu Pharmaceutical Corporation Information 7.1.2 Hisamitsu Pharmaceutical Description and Business Overview 7.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered 7.1.5 Hisamitsu Pharmaceutical Recent Development 7.2 Novartis 7.2.1 Novartis Corporation Information 7.2.2 Novartis Description and Business Overview 7.2.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Novartis Transdermal Skin Patch Products Offered 7.2.5 Novartis Recent Development 7.3 Johnson & Johnson 7.3.1 Johnson & Johnson Corporation Information 7.3.2 Johnson & Johnson Description and Business Overview 7.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered 7.3.5 Johnson & Johnson Recent Development 7.4 Teikoku Pharma 7.4.1 Teikoku Pharma Corporation Information 7.4.2 Teikoku Pharma Description and Business Overview 7.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered 7.4.5 Teikoku Pharma Recent Development 7.5 Mylan 7.5.1 Mylan Corporation Information 7.5.2 Mylan Description and Business Overview 7.5.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Mylan Transdermal Skin Patch Products Offered 7.5.5 Mylan Recent Development 7.6 Actavis 7.6.1 Actavis Corporation Information 7.6.2 Actavis Description and Business Overview 7.6.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Actavis Transdermal Skin Patch Products Offered 7.6.5 Actavis Recent Development 7.7 Mundipharma 7.7.1 Mundipharma Corporation Information 7.7.2 Mundipharma Description and Business Overview 7.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Mundipharma Transdermal Skin Patch Products Offered 7.7.5 Mundipharma Recent Development 7.8 Henan Lingrui Pharmaceutical 7.8.1 Henan Lingrui Pharmaceutical Corporation Information 7.8.2 Henan Lingrui Pharmaceutical Description and Business Overview 7.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered 7.8.5 Henan Lingrui Pharmaceutical Recent Development 7.9 Changzhou Siyao 7.9.1 Changzhou Siyao Corporation Information 7.9.2 Changzhou Siyao Description and Business Overview 7.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered 7.9.5 Changzhou Siyao Recent Development 7.10 Rfl Pharmaceutical 7.10.1 Rfl Pharmaceutical Corporation Information 7.10.2 Rfl Pharmaceutical Description and Business Overview 7.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered 7.10.5 Rfl Pharmaceutical Recent Development 7.11 Luye Pharma Group Ltd. 7.11.1 Luye Pharma Group Ltd. Corporation Information 7.11.2 Luye Pharma Group Ltd. Description and Business Overview 7.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Products Offered 7.11.5 Luye Pharma Group Ltd. Recent Development 7.12 Purdue Pharma L.P. 7.12.1 Purdue Pharma L.P. Corporation Information 7.12.2 Purdue Pharma L.P. Description and Business Overview 7.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Purdue Pharma L.P. Products Offered 7.12.5 Purdue Pharma L.P. Recent Development 7.13 Teva Pharmaceutical Industries Ltd. 7.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information 7.13.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview 7.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Teva Pharmaceutical Industries Ltd. Products Offered 7.13.5 Teva Pharmaceutical Industries Ltd. Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Transdermal Skin Patch Industry Chain Analysis 8.2 Transdermal Skin Patch Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Transdermal Skin Patch Distributors 8.3 Transdermal Skin Patch Production Mode & Process 8.4 Transdermal Skin Patch Sales and Marketing 8.4.1 Transdermal Skin Patch Sales Channels 8.4.2 Transdermal Skin Patch Distributors 8.5 Transdermal Skin Patch Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Transdermal Skin Patch CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Transdermal Skin Patch Market Trends Table 3. Transdermal Skin Patch Market Drivers Table 4. Transdermal Skin Patch Market Challenges Table 5. Transdermal Skin Patch Market Restraints Table 6. Global Transdermal Skin Patch Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Transdermal Skin Patch Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Transdermal Skin Patch Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Transdermal Skin Patch Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Transdermal Skin Patch Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Transdermal Skin Patch Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Transdermal Skin Patch Revenue Share by Manufacturer, 2017-2022 Table 13. Global Transdermal Skin Patch Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Transdermal Skin Patch Sales Share by Manufacturer, 2017-2022 Table 15. Global Transdermal Skin Patch Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Transdermal Skin Patch Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Skin Patch as of 2021) Table 18. Top Players of Transdermal Skin Patch in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Transdermal Skin Patch Product Type Table 20. Date of International Manufacturers Enter into Transdermal Skin Patch Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Transdermal Skin Patch Players in United States Market, Ranking by Revenue (2021) Table 23. United States Transdermal Skin Patch Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Transdermal Skin Patch Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Transdermal Skin Patch Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Transdermal Skin Patch Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Transdermal Skin Patch Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Transdermal Skin Patch Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Transdermal Skin Patch Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Transdermal Skin Patch Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Transdermal Skin Patch Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Transdermal Skin Patch Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Transdermal Skin Patch Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Transdermal Skin Patch Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Transdermal Skin Patch Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Transdermal Skin Patch Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Transdermal Skin Patch Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Transdermal Skin Patch Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Transdermal Skin Patch Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Transdermal Skin Patch Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Transdermal Skin Patch Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Hisamitsu Pharmaceutical Corporation Information Table 43. Hisamitsu Pharmaceutical Description and Business Overview Table 44. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Table 46. Hisamitsu Pharmaceutical Recent Development Table 47. Novartis Corporation Information Table 48. Novartis Description and Business Overview Table 49. Novartis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Novartis Product Table 51. Novartis Recent Development Table 52. Johnson & Johnson Corporation Information Table 53. Johnson & Johnson Description and Business Overview Table 54. Johnson & Johnson Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Johnson & Johnson Product Table 56. Johnson & Johnson Recent Development Table 57. Teikoku Pharma Corporation Information Table 58. Teikoku Pharma Description and Business Overview Table 59. Teikoku Pharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Teikoku Pharma Product Table 61. Teikoku Pharma Recent Development Table 62. Mylan Corporation Information Table 63. Mylan Description and Business Overview Table 64. Mylan Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Mylan Product Table 66. Mylan Recent Development Table 67. Actavis Corporation Information Table 68. Actavis Description and Business Overview Table 69. Actavis Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Actavis Product Table 71. Actavis Recent Development Table 72. Mundipharma Corporation Information Table 73. Mundipharma Description and Business Overview Table 74. Mundipharma Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Mundipharma Product Table 76. Mundipharma Recent Development Table 77. Henan Lingrui Pharmaceutical Corporation Information Table 78. Henan Lingrui Pharmaceutical Description and Business Overview Table 79. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. Henan Lingrui Pharmaceutical Product Table 81. Henan Lingrui Pharmaceutical Recent Development Table 82. Changzhou Siyao Corporation Information Table 83. Changzhou Siyao Description and Business Overview Table 84. Changzhou Siyao Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Changzhou Siyao Product Table 86. Changzhou Siyao Recent Development Table 87. Rfl Pharmaceutical Corporation Information Table 88. Rfl Pharmaceutical Description and Business Overview Table 89. Rfl Pharmaceutical Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Rfl Pharmaceutical Product Table 91. Rfl Pharmaceutical Recent Development Table 92. Luye Pharma Group Ltd. Corporation Information Table 93. Luye Pharma Group Ltd. Description and Business Overview Table 94. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 95. Luye Pharma Group Ltd. Product Table 96. Luye Pharma Group Ltd. Recent Development Table 97. Purdue Pharma L.P. Corporation Information Table 98. Purdue Pharma L.P. Description and Business Overview Table 99. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 100. Purdue Pharma L.P. Product Table 101. Purdue Pharma L.P. Recent Development Table 102. Teva Pharmaceutical Industries Ltd. Corporation Information Table 103. Teva Pharmaceutical Industries Ltd. Description and Business Overview Table 104. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 105. Teva Pharmaceutical Industries Ltd. Product Table 106. Teva Pharmaceutical Industries Ltd. Recent Development Table 107. Key Raw Materials Lists Table 108. Raw Materials Key Suppliers Lists Table 109. Transdermal Skin Patch Customers List Table 110. Transdermal Skin Patch Distributors List Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Transdermal Skin Patch Product Picture Figure 2. Global Transdermal Skin Patch Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Transdermal Skin Patch Market Size 2017-2028 (US$ Million) Figure 4. Global Transdermal Skin Patch Sales 2017-2028 (K Units) Figure 5. United States Transdermal Skin Patch Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Transdermal Skin Patch Market Size 2017-2028 (US$ Million) Figure 7. United States Transdermal Skin Patch Sales 2017-2028 (K Units) Figure 8. United States Transdermal Skin Patch Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Transdermal Skin Patch Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Transdermal Skin Patch Report Years Considered Figure 11. Product Picture of Fentanyl Transdermal Skin Patch Figure 12. Product Picture of Nicotine Transdermal Skin Patch Figure 13. Product Picture of Clonidine Transdermal Skin Patch Figure 14. Product Picture of Buprenorphine Transdermal Skin Patch Figure 15. Global Transdermal Skin Patch Market Share by Type in 2022 & 2028 Figure 16. Global Transdermal Skin Patch Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Transdermal Skin Patch Sales Market Share in Value by Type (2017-2028) Figure 18. Global Transdermal Skin Patch Sales by Type (2017-2028) & (K Units) Figure 19. Global Transdermal Skin Patch Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Transdermal Skin Patch Price by Type (2017-2028) & (USD/Unit) Figure 21. United States Transdermal Skin Patch Market Share by Type in 2022 & 2028 Figure 22. United States Transdermal Skin Patch Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Transdermal Skin Patch Sales Market Share in Value by Type (2017-2028) Figure 24. United States Transdermal Skin Patch Sales by Type (2017-2028) & (K Units) Figure 25. United States Transdermal Skin Patch Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Transdermal Skin Patch Price by Type (2017-2028) & (USD/Unit) Figure 27. Product Picture of Relieve Severe Pain Figure 28. Product Picture of Stop Smoking Cigarettes Figure 29. Product Picture of Treat an Overactive Bladder Figure 30. Product Picture of Others Figure 31. Global Transdermal Skin Patch Market Share by Application in 2022 & 2028 Figure 32. Global Transdermal Skin Patch Sales in Value by Application (2017-2028) & (US$ Million) Figure 33. Global Transdermal Skin Patch Sales Market Share in Value by Application (2017-2028) Figure 34. Global Transdermal Skin Patch Sales by Application (2017-2028) & (K Units) Figure 35. Global Transdermal Skin Patch Sales Market Share in Volume by Application (2017-2028) Figure 36. Global Transdermal Skin Patch Price by Application (2017-2028) & (USD/Unit) Figure 37. United States Transdermal Skin Patch Market Share by Application in 2022 & 2028 Figure 38. United States Transdermal Skin Patch Sales in Value by Application (2017-2028) & (US$ Million) Figure 39. United States Transdermal Skin Patch Sales Market Share in Value by Application (2017-2028) Figure 40. United States Transdermal Skin Patch Sales by Application (2017-2028) & (K Units) Figure 41. United States Transdermal Skin Patch Sales Market Share in Volume by Application (2017-2028) Figure 42. United States Transdermal Skin Patch Price by Application (2017-2028) & (USD/Unit) Figure 43. North America Transdermal Skin Patch Sales in Volume Growth Rate 2017-2028 (K Units) Figure 44. North America Transdermal Skin Patch Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 45. U.S. Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 46. Canada Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. Europe Transdermal Skin Patch Sales in Volume Growth Rate 2017-2028 (K Units) Figure 48. Europe Transdermal Skin Patch Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 49. Germany Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. France Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. U.K. Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Italy Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Russia Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Asia-Pacific Transdermal Skin Patch Sales in Volume Growth Rate 2017-2028 (K Units) Figure 55. Asia-Pacific Transdermal Skin Patch Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 56. China Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Japan Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. South Korea Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. India Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Australia Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Taiwan Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Indonesia Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Thailand Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Malaysia Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Philippines Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Latin America Transdermal Skin Patch Sales in Volume Growth Rate 2017-2028 (K Units) Figure 67. Latin America Transdermal Skin Patch Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 68. Mexico Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Brazil Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Argentina Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Middle East & Africa Transdermal Skin Patch Sales in Volume Growth Rate 2017-2028 (K Units) Figure 72. Middle East & Africa Transdermal Skin Patch Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 73. Turkey Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Saudi Arabia Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. U.A.E Transdermal Skin Patch Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Transdermal Skin Patch Value Chain Figure 77. Transdermal Skin Patch Production Process Figure 78. Channels of Distribution Figure 79. Distributors Profiles Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed
Hisamitsu Pharmaceutical Novartis Johnson & Johnson Teikoku Pharma Mylan Actavis Mundipharma Henan Lingrui Pharmaceutical Changzhou Siyao Rfl Pharmaceutical Luye Pharma Group Ltd. Purdue Pharma L.P. Teva Pharmaceutical Industries Ltd.
Radiotherapy Equipment market is segmented by region (country), players, by Type and by Applicati ... Read More
Animal Feed Trace Mineral Supplement market is segmented by region (country), players, by Type an ... Read More
Lithium Ion Battery Pack market is segmented by region (country), players, by Type and by Applica ... Read More
Firefighter Uniform Fabrics market is segmented by region (country), players, by Type and by Appl ... Read More